Contraception News and Research

Latest Contraception News and Research

IOM to issue report on preventive health care services for women

Is there nothing in last year's Affordable Care Act that people won't fight over? The latest battle is set to come to a head Wednesday, when the independent Institute of Medicine is expected to make recommendations about preventive health care services for women.

20 Jul 2011

First Edition: July 19, 2011

Kaiser Health News staff writer Christopher Weaver reports: "New consumer-controlled health insurance plans could get seed money from the government to increase competition - and maybe cut prices -- under new rules announced Monday by the Department of Health and Human Services".

19 Jul 2011

Thalidomide analog shows promise against sickle cell disease

A thalidomide analog is shaping up as a safe, worthy opponent of sickle cell disease, Georgia Health Sciences University researchers report.

19 Jul 2011

State roundup: Model insurance brings 'modest' savings

Blue Cross Blue Shield of Massachusetts' alternative quality contract, which Governor Deval Patrick has held up as a potential model for controlling health care costs, produced "modest" savings in its first year while yielding improved quality of care in some areas, according to a new study in this week's New England Journal of Medicine.

15 Jul 2011

Viewpoints: Teaching hospital cuts; Medicare & debt deal politics; end-of-life care

Teaching hospitals educate the next generation of physicians—who are clearly essential for our future. But the importance of academic medical centers and teaching hospitals goes far beyond delivering care.

15 Jul 2011

First Edition: July 14, 2011

Today's headlines include reports about how tempers are flaring in the midst of debt-ceiling negotiations, and how failure to reach an agreement could lead to tough choices about which of the nation's obligations will be left unpaid.

14 Jul 2011

Eisai's DACOGEN sNDA for acute myeloid leukemia accepted by FDA for review

SuperGen, Inc., a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced that Eisai Inc. today released information that the U.S. Food and Drug Administration (FDA) has accepted for review its supplemental New Drug Application (sNDA) seeking approval of DACOGEN (decitabine) for injection in the treatment of acute myeloid leukemia.

14 Jul 2011

FDA accepts Eisai's DACOGEN sNDA for review to treat acute myeloid leukemia

Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review its supplemental New Drug Application (sNDA) seeking approval of DACOGEN (decitabine) for injection in the treatment of acute myeloid leukemia.

13 Jul 2011

Many women in war-torn areas unable to obtain family planning services

Many areas of the world are at war and both the conflict and aftermath have dire consequences for the health of people affected. New research published in BioMed Central's open access journal Conflict and Health reports that while women in war-torn areas want access to family planning, these services are often not available at local hospitals or health centers.

13 Jul 2011

Family planning essential for meeting world population's needs

"I'd like to pose the question: what more must we do to ensure the health, nutritional, and educational needs of all seven billion are met?" Scott Radloff, director of USAID's Office of Population and Reproductive Health, writes about World Population Day on the agency's "IMPACTblog."

13 Jul 2011

Romantic fiction bad for marriages and love life!

According to a warning in the British Medical Journal (BMJ) seemingly innocent and harmless romantic fiction may also be a cause of marital breakdown, adulterous affairs and unwanted pregnancies. This comes from an article in the Journal of Family Planning and Reproductive Health Care, which said women struggle to distinguish between romantic fiction and real life.

10 Jul 2011

Longer looks: Shortage of HIV doctors; Oregon program builds on British model

Of the 3,155 U.S.-based members of the HIV Medicine Assn., 45% are older than 50, according to a March 17 Institute of Medicine report on HIV screening and access to care.

8 Jul 2011

SOGC launches first Facebook game about healthy sexuality for Canadians

Today, the Society of Obstetricians and Gynaecologists of Canada is launching its first Facebook game - Sex Quest - to help Canadians learn about healthy sexuality, contraception and STIs.

27 Jun 2011

Conference examines family planning benefits for health

Family planning "is one of the most cost-effective ways to prevent illness and save lives in the world's poor countries," according to health experts gathered in Addis Ababa, Ethiopia, at a conference sponsored by the Reproductive Health Supplies Coalition, GlobalPost's "Africa Emerges" blog reports.

24 Jun 2011

Focus on men in family planning programs

Scott Radloff, director of the Office of Population and Reproductive Health, writes about involving men in family planning on USAID's "Impact Blog."

21 Jun 2011

Celgene announces data from REVLIMID plus rituximab Phase II study on malignant lymphomas

Celgene International Sàrl announced that clinical data from a Phase II study, conducted by investigators from the MD Anderson Cancer Center in Houston, TX, evaluating the combination regimen of REVLIMID plus rituximab (R2) in untreated, advanced stage, indolent B-cell non-Hodgkin's lymphomas, were presented at the 11th International Conference on Malignant Lymphoma in Lugano, Switzerland.

18 Jun 2011

Celgene, GELA to conduct REVLIMID/rituximab combination study on newly diagnosed FL

Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Celgene International Sarl today announced a collaboration to conduct an international randomized study to evaluate the therapeutic potential of the REVLIMID/rituximab combination regimen (R2) in patients with newly diagnosed follicular lymphoma.

17 Jun 2011

REVLIMID-R-CHOP Phase I/II data in untreated DLBCL presented at malignant lymphoma conference

Celgene International Sàrl announced that clinical data from two studies evaluating the use of REVLIMID® (lenalidomide) with standard R-CHOP chemotherapy in patients with untreated diffuse large B cell (DLBCL) or grade 3 follicular lymphoma were presented at the 11th International Conference on Malignant Lymphoma in Lugano, Switzerland.

17 Jun 2011

Viewpoints: Medicare eligibility age; Medicare 'scares'; questions about Fla. Medicaid managed care

The bottom line is that we probably need to start raising Medicare's eligibility age incrementally, given today's life-expectancy realities. But it is not going to be the silver bullet that saves Medicare.

17 Jun 2011

State roundup: Mass. health spending's rise; huge Ky. hospital merger

A new report from the state Division of Health Care Finance and Policy shows that: ... "Spending per member on privately insured people grew 6 percent from 2007 to 2008 and another 10 percent from 2008 to 2009. This rate of growth was substantially higher than the increase in national personal health care expenditures per capita of 4.6 percent from 2008 to 2009. Spending by private payers also grew faster than spending by public payers".

16 Jun 2011